Check out how key tactics for laboratory outreach can increase revenues, decrease cost, and improve patient care.
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
Demyelinating neuropathies - Insights
Learn how our expert-backed testing can increase confidence when it comes to the identification of several demyelinating neuropathies.
What's New in Health Care Reform: Dec.12 - Insights
Top highlights include: how hospitals are fighting burnout, U.S. health spending hits $3.5 trillion but growth slows, why states might start taxing opioids, telemedicine in reverse. and health care providers are teaming with chatbots to...
How to Cut Costs without Cutting Corners - Insights
Nicole Folken, Education Specialist at Mayo Medical Laboratories, discusses how to cut costs without cutting corners when planning a conference or meeting.
Immunobullous Diseases: Paraneoplastic Pemphigus (PNP) - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss a rare and potentially fatal mucocutaneous blistering disease that is often associated with an underlying malignancy, called paraneoplastic pemphigus. She will also discuss the...
New gene panel enhances brain tumor profiles - Insights
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.
MayoComplete Solid Tumor Panel - Insights
Kevin Halling, M.D., Ph.D., explains how the MayoComplete Solid Tumor panel uses next-generation sequencing to assess 514 clinically significant, cancer-related genes for genetic alterations that offer insight on treatment effectivity.
What's New in Health Care Reform: Jan. 2 - Insights
Top highlights include: "big pharma" returning to raising U.S. prices in January after pause; crowdfunding drives funds and attention toward questionable medical treatments; Americans rate health care providers high on honesty, ethics,...